SEBI Grants Approval for Zepto's $1 Billion IPO

The 10-minute delivery app, Zepto, which recently transitioned from Zepto Private Limited to Zepto Limited in December 2025, as part of its IPO strategy, has reportedly secured approval for its initial public offering from the Securities and Exchange Board of India (SEBI).

According to media reports, the company is preparing for a public market debut that could raise approximately $1.3 billion, which is roughly ₹ 11,000-12,000 crore.

Now that regulatory approval has been granted, the Bengaluru-based startup is expected to submit its Updated Draft Red Herring Prospectus (UDRHP) within the next six to eight weeks, advancing its progress toward an initial public offering.

The listing is projected for the July-September quarter of 2026 and could become one of the largest IPOs in the quick-commerce sector, positioning the company to take on its already listed rivals, Swiggy and Zomato.

In preparation for its IPO, Zepto reportedly selected several investment banks, including Goldman Sachs, Morgan Stanley, and JM Financial, to serve as its bankers as early as September 2024.

About Zepto Limited 

Founded in July 2021 by two teenagers, Zepto has emerged as a leading player in India's quick commerce sector. Headquartered in Bangalore, the company utilises a dark store model, employing warehouses specifically optimised for rapid picking, packing, and ultra-fast delivery.

Zepto currently provides a diverse catalogue of over 7,000 products, encompassing everything from fresh produce and household essentials to personal care items and electronics.

Zepto raised $450 million in October last year at a $7 billion valuation, with the round including both primary and secondary transactions. Following that fundraiser, the company sharply stepped up customer acquisition efforts, increasing discounts and removing platform fees in several markets as competition intensified.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.